Skp Antibodies

Santa Cruz Biotechnology features a diverse variety of Skp Antibodies for various research applications. Skp Antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Skp, a component of the SCF (Skp1-Cullin-F-box) ubiquitin ligase complex, plays a crucial role in the regulation of protein degradation and cell cycle progression. By mediating the ubiquitination of target proteins, Skp maintains cellular homeostasis and responds to various stress signals. The involvement of Skp in the degradation of key regulatory proteins makes it a significant player in cancer biology and other diseases. Skp has been identified as a potential therapeutic target in multiple cancer types, with its expression levels correlating with disease progression and patient outcomes. Understanding Skp's molecular mechanisms can provide valuable insights into cell cycle regulation and protein degradation pathways. Research utilizing Skp monoclonal antibodies from Santa Cruz Biotechnology continues to advance our understanding of cellular processes and disease mechanisms, supporting scientific progress in cancer research and therapeutic development.